abstract |
The present disclosure provides a modified recombinant retrovirus comprising a 2A peptide or peptide-like coding sequence operably linked to a heterologous polynucleotide. The present disclosure further relates to cells and vectors that express or contain such vectors, and methods of using such modified vectors in the treatment of diseases and disorders. [Selection] Figure 3 |